All studies of deviance are plagued by the difficulty of estimating prevalence; accusers use the numerator and defenders the denominator.' In thinking about the problems in Britain earlier this year I could remember only five cases of medical misconduct (a blanket term to cover plagiarism and misrepresentation as well as outright fraud) (box). Nevertheless, a friendly radiologist told me about a much earlier case-which if not the first proved case in British medicine certainly seems likely to have provoked the first formal retraction in a medical journal.
Introduction
All studies of deviance are plagued by the difficulty of estimating prevalence; accusers use the numerator and defenders the denominator.' In thinking about the problems in Britain earlier this year I could remember only five cases of medical misconduct (a blanket term to cover plagiarism and misrepresentation as well as outright fraud) (box). Nevertheless, a friendly radiologist told me about a much earlier case-which if not the first proved case in British medicine certainly seems likely to have provoked the first formal retraction in a medical journal.
In 1916 the BMJ published an article about the work done by James Shearer, an American physician working in the British Army as a sergeant (because he had no British qualification). He had described a "delineator" which was better than x rays for portraying gunshot wounds (fig 1 (top), fig 2) .' This caused a sensation and a lot of interest -but on investigation the work was found to have been invented. The BM7 published a retraction (fig 1 (bottom) ),8 but Shearer was tried by court martial and sentenced to death by firing squad.9 Fortunately, the sentence was commuted to penal servitude, but Shearer died only a year later in prison. Unfortunately, the details are held in secret files until 2017, but the story brings a macabre twist to the well known New Yorker cartoon (fig 3) . Six cases in medicine over, say, 70 years do not seem very many-in fact this is much closer to Koshland's estimate of purity of 99 9999% of pieces of scientific information'0 than to the estimate by Broad moved to another department by the time of discovery and the new one disclaimed any responsibility. Only one perpetrator (not in this country) had been dismissed. I have summarised four of the documented episodes in Australia (see main box). A notable feature was the way that in two cases appeals about the administrative details had been used to delay the process of inquiry. On the other hand, all'of these cases had been brought into the open with official inquiries, and this had also happened eventually in another, non-medical, instance of plagiarism at the University of Newcastle, New South Wales.'9
Discussion
My small non-systematic survey found that misconduct in medical research certainly exists outside the United States but again provides no data on its prevalence. Nevertheless, most of these cases seem to be known to only a few people, little of the published work was retracted (and when it was so only in the vaguest of terms), and in Britain few institutions have any formal mechanism for dealing with instances of medical misconduct.
Clearly, the informality of the survey might be criticised. There were few ways of checking many of the statements, and yet they rang true for several reasons. Firstly, I knew most of the respondents (being able to address half of them by their Christian names); secondly, five of the cases were corroborated independently by other replies; and, thirdly, given the circumstances of the inquiry, the respondents had nothing to gain or lose from their replies.
ARE THE NUMBERS UNDERESTIMATES?
If anything, the results underestimate the true number of cases because total confidentiality was sometimes preserved: one respondent who had been concerned with a case as an examiner did not tell me about it (though he gave details of another case), but a friend of his (and mine) did; another respondent told me of a well authenticated case but said that he had been sworn to secrecy about the details (hence classified in table III under rumour). And sometimes in discussing the problem with outsiders I was told about yet other cases, which I added to the list if sufficient details were available. Finally, the survey did not cover other major disciplines, such as obstetrics and gynaecology or paediatrics, or subjects in which misconduct might be fairly common (such as clinical pharmacology), and I wrote to only one professor of surgery and medicine in each medical school, another feature which was liable to underestimate the true figures.
The pattern of misconduct resembles that of the 11~~~~~~~~4 in detecting misconduct of peer review in its broadest sense (at various stages of applying for a research grant, informal presentation of the work, editorial refereeing, and subsequent scrutiny of the published paper or attempted replication of the work).
FATE OF WHISTLEBLOWERS
Usually the fate of the whistleblower was not stated, but concern that they may be victimised has been raised in some reports from the United States. In two of my cases the whistleblower had suffered: both had found it necessary to resign, one when he found that his head of department had invented data but the circumstances were such that any inquiry would have been impossible.
I was surprised at the many respondents who knew of no cases at all, particularly as in a few instances their colleague at the same medical school told me of a well authenticated instance there. Apart from the trusting good nature of these respondents, this argues for a high degree of local confidentiality (in other words, they preferred not to tell their colleagues). Several respondents mentioned the legal implications of even a whisper of fraud, four of them preferring to telephone me with the details. Even if totally untrue such a taint might have serious implications for the future career of a research worker or clinician.
I was also surprised at the many editors who had not encountered misconduct, though many of them said that they had been "uneasy" about several articles (usually because the data seemed too good to be true); usually the implications of doing anything were too daunting in terms of time or legal hazards, and they had rejected the paper on general grounds. Perhaps the current dilemma was best put by the senior editor of a prestigious monthly journal: "Nearing the end of my time as editor the one thing I have really disliked is the prospect of receiving one article or letter a week containing data that I really don't believe."
On the other hand, at least one undoubted perpetrator was said to have brazened it out, threatening to sue his chief if he instituted disciplinary proceedings and retracted the published fraudulent work. His chief's resolve collapsed and nothing was done.
CONFUSION, HORROR OF PUBLICITY, AND SLOWNESS
In Britain all my findings echo those described in the United States by Angell,24 who commented that the initial responses to the early cases of fraud were marked by confusion and a horror of going public; action was also slow. Woolf has also suggested that, given that cases of misconduct (particularly plagiarism) are often handled locally, the total number is likely to be underestimated and that lawyers may often have an important role in preventing the disclosure of information and examination of the circumstances.' And not infrequently -particularly in the case of students detected who have invented or plagiarised data for a thesis-a bargain is struck: the thesis is disallowed and the student allowed to resign with nothing said publicly on the other side.
Medical Nevertheless, misconduct is an undoubted feature of contemporary science, being present even in the Soviet Union (where fraudulent results were used to damn a rival improved manufacturing process27). Its stigma is such that an innocent head of department, and a legitimate co-author of a fraudulent paper, committed suicide when his colleague was shown to have invented the data,28 and a friend of mine, a head of department, was utterly devastated when he found that a co-author colleague had invented the results; although at all stages he behaved with complete integrity, ensuring that due process was followed and that the article was retracted, he still finds the whole episode almost too painful to think about.
Much more important even than the serious incidents that recent inquiries have shown, however, are the sloppy standards of scientific work, authorship, and editing that have been disclosed. 33 Nobody could accuse either of fraud, but they had certainly published too many papers bearing their names-in three years one had almost 200 papers bearing his name, the other almost 100. I find these figures, and the ethos they represent, absurd; nobody can possibly take responsibility for this number of articles.
Finally, the committee of inquiry into the Slutsky episode was surprised at the extent to which the co-authors had passively accepted the events.'3 None had written to the journals asking for the articles to be retracted, and none had showed any interest in repeating the experiments or the calculations. The response of the journal editors was equally disappointing. Some said that they did not publish retractions, others that they did so only if all the co-authors agreed, and yet others did not answer letters making official requests to do so.
ACTION NEEDED IN BRITAIN
Given all this, the next stop should be for the British authorities to recognise the situation and resolve to tackle it. So far as sloppy science is concerned the solution must be with the individual institutions-particularly the heads of departments-in tackling the problems of gift authorship, salami publication, and duplicate publication. Editors can help, but the prime responsibility for standards is that of the institution.
For plagiarism and fraud concerted official action is needed. One There is no evidence that either saccharin or aspartame are carcinogenic in normal usage. The more recently introduced substitutes such as aspartame have been through an exhaustive series of toxicological studies and no carcinogenic effects were observed. The recent debate about aspartame centres on possible effects on mood and behaviour from its amino acid components. In the case of saccharin studies in rats showed an association with bladder cancers. These were at high levels of usage and a detailed examination of the incidence of bladder cancer in humans, especially diabetics with a high use of sugar substitutes, has shown no increased risk associated with the use of sweeteners.'2-D A T SOUTHGATE, head, nutrition and food quality research, AFRC Food Research Institute, Norwich.
